Actively Recruiting
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Led by Incyte Biosciences Italy S.r.l · Updated on 2024-05-22
200
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
Sponsors
I
Incyte Biosciences Italy S.r.l
Lead Sponsor
A
Advice Pharma Group srl
Collaborating Sponsor
AI-Summary
What this Trial Is About
The PRO-MIND study is an Italian, multicenter, prospective observational cohort study to evaluate the effectiveness and the safety of tafasitamab in combination with lenalidomide followed by tafasitamab monotherapy in patient with DLBCL.
CONDITIONS
Official Title
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients are aged 18 years or older.
- Patients with relapsed or refractory Diffuse Large B-cell Lymphoma who are not eligible for transplant.
- Patients starting treatment with commercially available tafasitamab and lenalidomide after signing informed consent.
- Patients able to provide signed informed consent.
You will not qualify if you...
- Participation in another interventional clinical study.
- Patients for whom reliable diagnosis or follow-up data cannot be obtained.
- Patients who started tafasitamab treatment before signing informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Incyte Biosciences Italy S.r.l
Milan, Italy, 20122
Actively Recruiting
Research Team
N
Nicola Battaglia
CONTACT
M
Mario Lapecorella
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here